Genocea Biosciences Company
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Founded Date:
2006-01-01
Estimated Revenue:
$10M to $50M
Total Funding:
470569774
Investors Number:
13
Employee Number:
51-100
Last Funding Type:
Post-IPO Equity
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Last Funding Date:
2020-07-22